ArtNr |
S2681-25 |
Hersteller |
Selleckchem
|
CAS-Nr. |
648449-76-7 |
Menge |
25 mg |
Quantity options |
100 mg
1 g
10 g
10 mM/1 ml
2 mg
25 mg
5 mg
5 g
|
Kategorie |
|
Typ |
Inhibitors |
Specific against |
other |
Smiles |
C1=CC2=C(C=C1C=C3C(=O)NC(=O)S3)OC(O2)(F)F |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
648449-76-7 ' |
Similar products |
AS-604850 |
Lieferbar |
|
Manufacturer - Targets |
PI3K |
Storage Conditions |
2 years -80 in solvent |
Molecular Weight |
285, 22 |
Administration |
Oral administration 30 or 15 minutes before injection of RANTES or thioglycollate |
Animal Models |
RANTES (0.5 mg/kg in 200 ml saline) or thioglycollate (40 ml/kg) are intraperitoneally injected to C3H mice to induce peritonitis mouse models |
Cell lines |
HepG2 Ntcp and Huh7-Ntcp cells |
Concentrations |
2.5 uM |
Dosages |
0, 1, 3, 10 or 30 mg/kg for RANTES, 10 mg/kg for thioglycollate |
Formulation |
AS-604850 is dissolved in vehicle (0.5% carboxymethylcellulose/0.25% Tween-20) and adjusted the solution to 10 mL/kg of body weight. |
IC50 |
250 nM, 250 nM, 250 nM, 250 nM, 250 nM, 250 nM |
In vitro |
AS-604850 is ATP-competitive PI3Kgamma inhibitor with Ki values of 0.18 uM. AS-604850 is isoform selective inhibitor of PI3Kgamma with over 30-fold selectivity for PI3Kgamma and beta, and 18-fold selectivity over PI3Kalpha. (PI3Kalpha: IC50 = 4.5 uM, PI3Kgamma and beta: IC50 > 20uM) AS-604850 is capable of inhibiting C5a-mediated PKB phosphorylation in RAW264 mouse macrophages with an IC50 with 10 uM. AS-604850 blocks MCP-1–mediated chemotaxis in Pik3cg +/+ monocytes in a concentration- dependent manner, with an IC50 of 21 mM, but dosn't affect chemotaxis in Pik3cg-/- cells, indicating that AS-604850 acts through PI3Kgamma. [1] AS-604850 diminishes glycochenodeoxycholate (GCDC) induced Akt-phosphorylation and apoptosis in rat hepatocytes. AS-604850 diminishes bile salt-induced apoptosis in HepG2 Ntcp and Huh7-Ntcp cells. [2] AS604850 causes a concentration-dependent suppression of chemotactic responses of EoL-1 cells and blood eosinophils to platelet-activating factor (PAF). [3] |
In vivo |
AS-604850 reduces RANTES-induced peritoneal neutrophil recruitment with a ED50 of 42.4 mg/kg. In the thioglycollate-induced peritonitis model, oral administration of 10 mg/kg AS-604850 results in a 31% reduction of neutrophil recruitment. [1] |
Incubation Time |
2 - 4 hours |
Kinase Assay |
In vitro PI3Kgamma Kinase Assay, Human PI3Kgamma (100 ng) is incubated at RT with kinase buffer (10 mM MgCl2, 1 mM beta-glycerophosphate, 1 mM DTT, 0.1 mM Na3VO4, 0.1% Na Cholate and 15 M ATP/100 nCi gamma[33]ATP, final concentrations) and lipid vesicles containing 18 M PtdIns and 250 M of PtdSer (final concentrations), in the presence of AS-252424 or DMSO. Kinase reaction is stopped by adding 250 g of Neomycin-coated Scintillation Proximity Assay (SPA) beads and preceded. |
Method |
Hepatocyte cultures are treated with diluent (DMSO), 25 uM TLC, 250 uM TCDC, 50 uM GCDC, or 50 ng/ml Fas for 2–4 hours HepG2-Ntcp and Huh7-Ntcp cells are treated with DMSO, 20 uM TLC, 75 uM TCDC or GCDC, 200 uM etoposide or 200 ng/ml TNFa plus 28 ng/ml actinomycin D for 2–4 hours. The number of apoptotic cells is determined morphologically using fluorescent staining and expressed as % of cells. Apoptosis is confirmed in human cell lines by determination of caspase-3/-7 activity and in rat hepatocytes by detection of the 17 kDa proteolytic cleavage fragment of caspase-3 by immunoblotting, equal protein loading is monitored by immunoblotting for actin. |
Solubility (25C) |
DMSO 57 mg/mL, Water <1 mg/mL, Ethanol 5 mg/mL |
Information |
AS-604850 is a selective, ATP-competitive PI3Kγ inhibitor with IC50 of 250 nM, over 80-fold selectivity for PI3Kγ than PI3Kδ/β, and 18-fold more selective for PI3Kγ than PI3Kα. |
Chemical Name |
(Z)-5-((2, 2-difluorobenzo[d][1, 3]dioxol-5-yl)methylene)thiazolidine-2, 4-dione |
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.